idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Developing countries stand to profit most from advances in genome science, write Samuel Broder, Stephen Hoffman and Peter Hotez in this month's issue of EMBO reports (EMBO reports September, 2002 pp 806-812). They claim that biotechnology coupled with genomics might emerge as the key technology in the 21st century for improving global health and probably even avoiding major political conflicts and wars.
The authors warn that we must no longer view the diseases of the developing world in purely medical or public health contexts. Infectious diseases could pose a major risk to the economic survival of many developing nations. Even more striking, recent data suggest that some of these diseases may have wider implications for geopolitical stability or the probability that a nation will experience armed conflict. "If it is possible to transfer weapon technology to the developing world it should be possible to transfer innovative countertechnologies to these countries. We believe that genomics could be such a countertechnology," says Samuel Broder.
The progress resulting from genomic research is significant. It has already advanced our knowledge of infectious diseases. The complete genomic sequences of many pathogens responsible for morbidity and mortality in the developing world are now established. The new tools in comparative genomics, computational biology, and informatics have already yielded promising results in studying invertebrate parasites that cause tropical diseases. When combined with the sequence of the human genome, and the sequence of some of the vectors of disease, like the Anopheles mosquitoes that transmit malaria parasites, they offer remarkable opportunities for reducing the negative impact of these diseases.
However, the authors point out that the applications of this research might only benefit patients in the First World, since there has been little or no commercial interest in developing treatments against the tropical diseases that occur among the world's poorest people. The authors illustrate this with several diseases such as malaria, hookworm and AIDS. "To achieve greater impact for the developing countries it will be necessary to combine the efforts made by some not-for-profit organisations and private funds to support research for the developing world and to link genomic research with vaccine research and other technologies." says Samuel Broder. "It will also be necessary to transfer these new technologies to developing countries and to give these countries access to necessary information, such as gene data bases."
contact
For interviews & further questions contact
Samuel Broder
Celera Genomics
Rockville, MD, USA
Sam.Broder@celera.com
Stephen L. Hoffman
Sanaria
308 Argosy Drive
Gaithersburg, MD 20878
slhoffman@sanaria.com
Peter J Hotez
Dept. Microbiology and Tropical Medicine
The George Washington University
Ross Hall,
Washington mtmpjh@gwumc.edu
To obtain a PDF of the full length article or photos of the authors please contact
Ellen Peerenboom
EMBO Press & Public Relations Officer
Postfach 102240
D69012 Heidelberg
Tel: 0049 6221 8891 108
Fax: 0049 6221 8891 200
ellen.peerenboom@embo.org
the authors
Samuel Broder
is vice president of medical affairs at Celera Genomics of Rockville, MD, an Applera Corporation business. He can be reached at sam.broder@celera.com
Stephen L. Hoffman
past president of the American Society of Tropical Medicine and Hygiene, is at Sanaria, Gaithersburg, MD slhoffman@sanaria.com
Peter J. Hotez
is Professor and Chair of the Department of Microbiology and Tropical Medicine at the George Washington University in Washington, DC and senior fellow and chairman of the Scientific Advisory Council of the Sabin Vaccine Institute, Rockville, MD, USA
mtmpjh@gwumc.edu
for authors photos see http://www.embo.org/press/reports/september.html and contact ellen.peerenboom@embo.org for better quality photos
full reference
Broder et al. (2002) Cures for the Third World's problems. EMBO reports vol. 3(9). 806-812
the journal
EMBO reports is more than just a scientific journal. It publishes a variety of sharply focused short papers, key reviews and meeting reports from all areas of molecular biology, thus keeping a broad readership abreast of the latest primary research. Its Science & Society section discusses the impact that politics, society and the financial world have on the environment in which the sciences are performed and visa versa are interesting for a broader audience.
http://www.embo.org/press/reports/september.html
Criteria of this press release:
Biology, Chemistry, Information technology, Law, Medicine, Nutrition / healthcare / nursing, Politics, Social studies
transregional, national
Science policy, Scientific Publications
German
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).
